Human immunoglobulin therapy for preeclampsia associated with lupus anticoagulant and anticardiolipin antibody

Published

Journal Article

A patient with lupus anticoagulant and anticardiolipin anti-body developed preeclampsia at 24 weeks’ gestation. Therapy with human immunoglobulin (Ig) resulted in stabilization of preeclampsia and suppression of the lupus anticoagulant. Anticardiolipin antibody titers were partially suppressed. Preeclampsia worsened at 32 weeks’ gestation, and a healthy infant was delivered. For patients with preeclampsia secondary to lupus anticoagulant before the fetus is viable, human Ig is a potential therapeutic option. © 1990 The American College of Obstetricians and Gynecologists.

Full Text

Cited Authors

  • Katz, VL; Thorp, JM; Watson, WJ; Fowler, L; Heine, RP

Published Date

  • January 1, 1990

Published In

Volume / Issue

  • 76 / 5

Start / End Page

  • 986 - 988

Electronic International Standard Serial Number (EISSN)

  • 1873-233X

International Standard Serial Number (ISSN)

  • 0029-7844

Digital Object Identifier (DOI)

  • 10.1097/00006250-199011000-00071

Citation Source

  • Scopus